Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
probe substrates
Description:
Substances selectively processed by enzymes and used to assess enzyme activity or metabolism in biochemical assays.
Primary topic:
Pharmacogenetics and Drug Metabolism (78%)
Related topics:
Pharmacogenetics and Drug Metabolism (78%),
Drug Transport and Resistance Mechanisms (13%)
OpenAlex ID:
keywords/probe-substrates
Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver
1994
·
M.Danny Burke
, Stephanie Thompson
, et al.
·
Biochemical Pharmacology
·
590
Evaluation of Cytochrome P450 Probe Substrates Commonly Used by the Pharmaceutical Industry to Study in Vitro Drug Interactions
2002
·
Rae Yuan
, Soraya Madani
, et al.
·
Drug Metabolism and Disposition
·
354
In Vitro P-glycoprotein Inhibition Assays for Assessment of Clinical Drug Interaction Potential of New Drug Candidates: a Recommendation for Probe Substrates
2006
·
Jarkko Rautio
, Joan E. Humphreys
, et al.
·
Drug Metabolism and Disposition
·
302
Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation ofin vitrometabolism using cDNA-expressed human P450s and human liver microsomes
1996
·
S. Ono
, T. Hatanaka
, et al.
·
Xenobiotica
·
290
Evaluation of 3′-azido-3′-deoxythymidine, Morphine, and Codeine as Probe Substrates for Udp-glucuronosyltransferase 2b7 (ugt2b7) in Human Liver Microsomes: Specificity and Influence of the Ugt2b7*2 Polymorphism
2003
·
Michael H. Court
, Soundarajan Krishnaswamy
, et al.
·
Drug Metabolism and Disposition
·
272
Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions
2016
·
Janne T. Backman
, Anne M. Filppula
, et al.
·
Pharmacological Reviews
·
263
A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry.
2001
·
E A Dierks
, K R Stams
, et al.
·
PubMed
·
260
Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities.
1998
·
D Hickman
, J P Wang
, et al.
·
PubMed
·
246
Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study
2004
·
D Wexler
, R Courtney
, et al.
·
European Journal of Pharmaceutical Sciences
·
211
Induction and Inhibition of Cytochromes P450 by the St. John’s Wort Constituent Hyperforin in Human Hepatocyte Cultures
2004
·
Bernard J. Komoroski
, Shimin Zhang
, et al.
·
Drug Metabolism and Disposition
·
200
Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants: Part II
2002
·
Jane Alcorn
, Patrick J. McNamara
·
Clinical Pharmacokinetics
·
182
Cytochrome P450 Fluorometric Substrates: Identification of Isoform-Selective Probes for Rat CYP2D2 and Human CYP3A4.
2002
·
David M. Stresser
, Stephanie D. Turner
, et al.
·
Drug Metabolism and Disposition
·
179
Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide 1B clinical probe than rosuvastatin
2014
·
Thomayant Prueksaritanont
, Xiaoyan Chu
, et al.
·
British Journal of Clinical Pharmacology
·
178
PDF
The Effect of Incubation Conditions on the Enzyme Kinetics of Udp-glucuronosyltransferases
2003
·
Matthew G. Soars
, Barbara J. Ring
, et al.
·
Drug Metabolism and Disposition
·
163
High‐throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry
2005
·
Min‐Jung Kim
, Hyojin Kim
, et al.
·
Rapid Communications in Mass Spectrometry
·
158
Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms
1992
·
Uwe fuhr
, Johannes Doehmer
, et al.
·
Biochemical Pharmacology
·
157
Prediction ofin vivodrug–drug interactions fromin vitrodata: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant
2005
·
Hayley S. Brown
, Kiyomi Ito
, et al.
·
British Journal of Clinical Pharmacology
·
154
Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A
2016
·
T Prueksaritanont
, DA Tatosian
, et al.
·
Clinical Pharmacology & Therapeutics
·
153
Assessment of Liver Metabolic Function: Clinical Implications
1994
·
Jürgen Brockmöller
, Ivar Roots
·
Clinical Pharmacokinetics
·
152
Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review
2004
·
J.L.C.M. Dorne
, K. Walton
, et al.
·
Food and Chemical Toxicology
·
148
A Critical Evaluation of the Experimental Design of Studies of Mechanism Based Enzyme Inhibition, with Implications for In Vitro-In Vivo Extrapolation
2006
·
F. Ghanbari
, K. Rowland-Yeo
, et al.
·
Current Drug Metabolism
·
143
Influence ofPanax ginsengon Cytochrome P450 (CYP)3A and P‐glycoprotein (P‐gp) Activity in Healthy Participants
2011
·
Christine Y. Malati
, Sarah M. Robertson
, et al.
·
The Journal of Clinical Pharmacology
·
141
Selection of Alternative CYP3A4 Probe Substrates for Clinical Drug Interaction Studies Using In Vitro Data and In Vivo Simulation
2010
·
Robert S. Foti
, Dan A. Rock
, et al.
·
Drug Metabolism and Disposition
·
137
Evaluation of Potential Inductive Effects of Aprepitant on Cytochrome P450 3A4 and 2C9 Activity
2004
·
Craig R. Shadle
, Yih Lee
, et al.
·
The Journal of Clinical Pharmacology
·
132
Characterization of Recombinant Human Carboxylesterases: Fluorescein Diacetate as a Probe Substrate for Human Carboxylesterase 2
2011
·
Jie Wang
, Eric T. Williams
, et al.
·
Drug Metabolism and Disposition
·
129
Show more works
View as search
Works count:
552
Citation count:
16,250
Year
Topic
Type